IAG Strategic Imaging for Accelerated Drug Development

Journal of Zhejiang University (Medical Sciences)

Accelerating the integration of China into the global development of innovative anticancer drugs - The Lancet Oncology

Accelerated Approval Program Virtual Public Meeting

Precision in medicine & AI in drug development - the same thing?

Accelerating Drug Development with Today's Innovation in Imaging

Strategic Use of Imaging Accelerates Drug Development & Reduces Risk of Failure

Artificial intelligence facilitates drug design in the big data era - ScienceDirect

AI in biopharma research: A time to focus and scale

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet

IAG announced new partnership in development of novel, targeted T-cell enhancing immuno-oncology therapeutics

The Many Faces of AI in Clinical Trials - Signify Research

IAG, IMAGE ANALYSIS GROUP na LinkedIn: Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic…

The Age of AI has begun